35
CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya

CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya

  • Upload
    paytah

  • View
    54

  • Download
    0

Embed Size (px)

DESCRIPTION

CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya. Clinical features . Clinical features of B.anthracis:. Anthrax is a zoonotic disease. Anthrax “coal” ,comes from black colour of eschar - PowerPoint PPT Presentation

Citation preview

Page 1: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

CLINICAL FEATURESEPIDEMIOLOGYLAB DIAGNOSISPROPHYLAXISTREATMENT

k.vanya

Page 2: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Clinical features

Page 3: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Clinical features of B.anthracis:Anthrax is a zoonotic disease.Anthrax “coal” ,comes from black

colour of escharRoute of infection: ingestion / inhalation of

spores /it may enter directly through skin.Infective material: discharges from mouth ,

nose &rectum of infected animals.The large no. of bacilli present in those

discharges sporulate in soil and remain as source of infection.

Direct spread from animal to animal is rare.

Page 4: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 5: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

it causes fatal septicemia, but some times it is localized/resemble cutaneous diseases in humans.

acquired from animals directly / indirectly.Based on clinical features, Anthrax is divided into 3 types

cutaneous pulmonary intestinal All these lead to fatal septicemia/meningitis

Page 6: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Cutaneous anthraxAlso called “hide porter’s disease”, as it is

common in dock workers,Route of infection: infection enter through

abraded skin.◦Also by shaving brushes made of animal hair

Usual sites: face,neck,hands,arms&back Lesion starts as papule 1-3 days after

infection

becomes vesicular (fluid clear/blood stained)

Page 7: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 8: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 9: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Malignant pustule:The whole area congested,

edematous & several satellite lesions filled with yellow fluid/serum arranged around central necrotic lesion which is covered by black eschar.

resolves spontaneously.Complications: 10-20% develop fatal

septicemia/meningitis

Page 10: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Malignant pustuleCongested

Edematous

Satellite lesions

Page 11: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Pulmonary anthraxAlso called “wool sorter’s disease”.Because it is common in wool

factories.Route of infection: due to inhalation

of dust from infected wool.More severe than others.Complications:

hemorrhagic pneumonia (common) hemorrhagic meningitis(rare)

Page 12: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 13: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Intestinal anthraxRareMainly in primitive communities

i.e. who eat dead bodies of animals died of anthrax.

Complication: violent enteritis with bloody

diarrhea with high fatality rate

Page 14: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 15: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

industrial Based on occupation non-industrial

Industrial: such as meat packing/wool factories.

Non-industrial: associated with animals(butchers

&farmers)

Page 16: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Rarely stomoxys calcitrans –biting insect transmit infection mechanically.

Page 17: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Epidemiology:Rare in western countriesLarge epidemics

russia&zimbabwe(1978-80)

Recently visakha agency has outbreaks of cutaneous anthrax

Andhra –tamilnadu region

Cutaneous,meningoencephalitic infections

Page 18: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Laboratory diagnosis

1)microscopy 2)culture

3)Animal inoculation 4)Serological

demonstration of anthrax Ag in

tissueType of test

based on availability

of specimens

Page 19: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Specimens: swab, fluid/pus from pustule-cutaneous anthrax

Sputum-pulmonary anthrax.Blood-septicemia anthrax.

Page 20: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Microscopy:Gram positive bacilli arranged in

large chains.

Page 21: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Capsule --Clear halo around bacillus in Indian ink preparation

Page 22: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Direct flourescent antibody test: capsule specific staining for poly saccharide Ag

Mc fadyean’s reaction :Amorphous purple material – characteristic of B.anthracis.

Employed for presumptive diagnosis in animals

Page 23: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Mc fadyean’s reaction

Page 24: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Culture : inoculated on nutrient agar incubate at 37 c for overnight.

-medusa head coloniesGelatin stab culture : inverted fir

tree

Page 25: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Animal inoculation : white mouse / guinea pigs injected with exudate /culture

Animal dies in 48 hrs

Page 26: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Serology ( Ascoli Thermo Precipitin Test ):

Tissues are ground up in saline and boiled for 5

mins and filtered. Then this extract layered over

anti anthrax serum in a narrow tube.

+ve case :ring of precipitate appears at junction of two liquids with in 5minutes.

mainly used for rapid diagnosis

when sample received is putrid and viable bacilli less likely found

Page 27: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

CDC(centers for disease control)guide lines:

Any large gram positive baciili with general morphology, cultural features of anthrax-non motile, on hemolytic on blood agar,catalase positive given presumptive report as anthrax.

Initial confirmation-lysis by gamma phage,DFA test.

Further confirmation:PCR test

Page 28: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Other methods :Polymerase chain reaction : used

for conformation of anthrax bacilli.

ELISA assay for antigen detectionX-ray and CT scanLysis by gamma phage

Page 29: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

PROPHYLAXIS:General methods : improvement of factory hygiene proper sterilization of animal

products , carcasses of animals suspected to have anthrax are buried deep in lime.

Page 30: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Active immunizationSpore is common infective formSterne vaccine contains spores of

non capsulated avirulent mutant strain

Animal is protected for a year with single injection of spore vaccine

Extensively used in animalsNot safe for human use

Page 31: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Contd….Alum precipitated toxoid

prepared from protective antigens used in persons occupationally exposed to anthrax infection.

Safe and effective in humansGiven in 3 doses IM at intervals

of 6 weeks

Page 32: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Treatment:Before 2001, 1st line of treatment

was penicillin G◦ Stopped for fear of genetically

engineered resistant strains60 day course of antibioticsCiprofloxacin

◦ fluoroquinolone◦ 500 mg tablet every 12h or 400 mg

IV every 12h ◦ Inhibits DNA synthesis

Doxycycline◦ 6-deoxy-tetracycline◦ 100 mg tablet every 12h or 100 mg

IV every 12h ◦ Inhibits protein synthesis

Page 33: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

For inhalational, need another antimicrobial agent◦ clindamycin ◦ rifampin ◦ chloramphenicol

Anthrax infection gives permanent immunity&2nd attacks are rare.

Page 34: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 35: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

THANK YOU